Previous Article | Next Article ![]()
Infection and Immunity, February 1999, p. 976-980, Vol. 67, No. 2
Department of Microbiology and Molecular
Genetics and Shipley Institute of Medicine, Harvard Medical School,
Boston, Massachusetts 02115
Received 24 August 1998/Returned for modification 27 October
1998/Accepted 9 November 1998
The toxin-coregulated pilus (TCP) of Vibrio cholerae is
essential for colonization. It was recently reported that
rfb mutations in V. cholerae 569B cause the
translocation arrest of the structural subunit of TCP, raising the
possibility that the colonization defects of lipopolysaccharide mutants
are due to effects on TCP biogenesis. However, an rfbB gene
disruption in either V. cholerae O395 or 569B has no
apparent effect on surface TCP production as assessed by immunoelectron
microscopy and CTX phage transduction, and an
rfbD::Tn5lac mutant of O395 also
shows no defect in TCP expression. We conclude that the colonization
defect associated with rfb mutations is unrelated to
defects in TCP assembly.
The gram-negative bacterium
Vibrio cholerae is the causative agent of the diarrheal
disease cholera. The profuse secretory diarrhea characteristic of
cholera is induced by cholera toxin (18), whose expression
is regulated by the ToxR and ToxT transcriptional activators
(24). ToxR and ToxT also coordinately regulate the biogenesis of the toxin-coregulated pilus (TCP) (19), a type IV pilus that is absolutely required for intestinal colonization in
infant mice and human volunteers (3, 15, 33, 34). TCP also
function as receptors for the CTX phage (37). Although TCP
are currently thought to play a traditional role in colonization, functioning as adhesin-carrying organelles for host receptors, there
are data suggesting that TCP may also alter other surface properties of
V. cholerae, rendering cells more hydrophobic
(33) and more resistant to the bacteriocidal action of
antibodies and complement (12). Bacterial cells expressing
high levels of TCP also display autoagglutination, a macroscopic
clumping phenomenon that may reflect an ability of V. cholerae to form microcolonies on the intestinal epithelium. A
similar autoaggregative phenotype is associated with type IV pilus
expression in enteropathogenic Escherichia coli and has been
shown to be important for the virulence of that organism in humans
(7).
The rfb genes of V. cholerae encode enzymes
necessary for lipopolysaccharide (LPS) biosynthesis (13, 32,
39). Previous studies correlated LPS mutations with colonization
defects in V. cholerae (11, 29, 36) and other
organisms (8, 9, 20, 28, 40), but the mechanism by which LPS
mutations decrease colonization remained obscure. However, it was
recently reported that an rfbD::Tn5
mutation in V. cholerae 569B prevents translocation of the
TcpA pilin, the structural subunit of TCP (17). If true, this finding suggests two possibilities. First, since TCP are critical
for colonization, the colonization defects of rfb mutants could be due to interference with proper TCP expression. Second, since
TcpA mutations result in serum sensitivity, a phenotype commonly
associated with LPS mutations, it is possible that improper TCP
assembly affects LPS structure or function.
While searching for genes required for colonization, we identified
rfbB and rfbL mutants as colonization-defective
strains (11). We accordingly constructed rfbB
mutations in V. cholerae O395 and 569B, and in contrast to a
previous report (17), we found no defect in the TCP
production of these rfb mutants, nor did we detect any
reduction in the TCP expression in an
rfbD::Tn5lac mutant of O395.
To construct a suicide vector for disrupting rfbB, an
internal fragment of rfbB was obtained from the chromosome
of V. cholerae C6709 (El Tor, Inaba) by PCR amplification
and cloned into pGP704 (23). The resulting plasmid, pSC95,
was introduced into O395 (classical, Ogawa) and 569B (classical, Inaba)
by plate mating from the E. coli donor SM10 SC512 was analyzed for several phenotypes expected of LPS mutants. As
noted with other V. cholerae rfb mutants (39),
SC512 exhibited less agglutination with anti-Ogawa typing serum (Difco Laboratories Inc.) in slide agglutination assays than did the parental
O395 strain (data not shown). In addition, LPS was purified from SC512
and O395 as described previously (30) and separated on a
sodium dodecyl sulfate-12.5% polyacrylamide gel. The patterns observed after silver staining (Fig. 1)
were consistent with those previously reported for wild-type and
rfb mutant V. cholerae (39). The
ability of SC512 to colonize infant mice was tested in competition assays (12) where a competitive index of less than one
indicated attenuation relative to a wild-type strain. As expected for
an LPS mutant, SC512 demonstrated a severe colonization defect (Table 1).
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
rfb Mutations in Vibrio
cholerae Do Not Affect Surface Production of Toxin-Coregulated
Pili but Still Inhibit Intestinal Colonization
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
pir
(33), and Apr Smr transconjugants
were selected for further analysis. Integration of pSC95 at the
rfbB locus was verified by Southern blot analysis (data not
shown) for strains SC512 (O395; rfbB::pSC95) and
SC539 (569B; rfbB::pSC95).

View larger version (27K):
[in a new window]
FIG. 1.
Silver-stained sodium dodecyl sulfate-12%
polyacrylamide gel of LPS purified from O395 and SC512. Silver staining
was carried out with the Bio-Rad (Hercules, Calif.) silver stain kit in
accordance with the manufacturer's directions. Numbers at the left are
molecular weights, in thousands.
TABLE 1.
SC512 phenotypes
Serum sensitivity is associated with LPS defects in several bacterial
species (14, 16, 36), and we tested SC512 in a serum
resistance competition assay (12, 36). SC512 and LAC-1 (O395
lacZ [38]) were cultured overnight in
Luria broth (LB), subcultured 1:100 into LB, and grown at 37°C to
mid-logarithmic phase. Cells were washed once in phosphate-buffered
saline, mixed at a 1:1 ratio of SC512 to LAC-1, and diluted 1:10 in
phosphate-buffered saline. This mixture was divided into aliquots to
which was added either untreated guinea pig serum or heat-inactivated
guinea pig serum to a final concentration of 10% serum. These samples
were incubated at 37°C for 1 h and subsequently plated on L agar
containing X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) to
differentiate between Lac+ SC512 and the LAC-1 control. In
this assay, SC512 was approximately 10,000-fold more serum sensitive
than LAC-1 (Table 1), as determined by comparing the ratio of SC512 to
LAC-1 after treatment with untreated guinea pig serum to the ratio of
SC512 to LAC-1 after treatment with heat-inactivated serum. The guinea
pig serum was obtained from Accurate Chemical and Scientific
Corporation (Westbury, N.Y.), and heat inactivation was performed by
heating at 55°C for 1 h.
Having established that SC512 displayed phenotypes consistent with an
rfb mutation, we examined the strain for phenotypes associated with TCP defects. Autoagglutination, colonization, and serum
resistance are all tightly linked to the expression of wild-type TCP
(12), but colonization and serum resistance could not in
this instance be used to assess TCP production because these phenotypes
are also predicted to be affected by LPS mutations. However, TCP also
function as CTX phage receptors, and TCP expression can be quantified
by a transduction assay employing pCTX-Km, a kanamycin-resistant
version of CTX phage (37). With this method, SC512 is as
transducible by CTX phage as wild-type V. cholerae (Table
2), indicating that the
rfbB::pSC95 mutation does not interfere with TCP
expression. LPS mutations do result in a type of autoagglutination, but
this autoagglutination is easily distinguishable from
TCP-mediated autoagglutination. SC512 showed wild-type,
TCP-mediated autoagglutination, further suggesting that TCP expression
is unaffected in SC512. Finally, Western analysis and immunoelectron
microscopy (IEM) were performed as previously described (12)
and showed that SC512 produces wild-type quantities of TcpA (data not
shown) and bundled surface TCP (Fig. 2a).
|
|
The results for SC512 clearly demonstrate that an rfbB mutation in O395 does not affect TCP expression. This is in contrast to a previous report asserting that rfb mutations block translocation of the TcpA pilin subunit, a finding that was based primarily on immunofluorescence and IEM analysis of a single rfbD mutant of 569B (17). Multiple studies with the infant mouse model had already demonstrated that 569B is a poorly colonizing strain of low virulence compared to other wild-type strains (1, 2, 4-6), and 569B carries a deletion of the regulatory gene toxS, which is required for full ToxR activation of the toxin and tcp genes in other strains of V. cholerae (22). We therefore initially thought that any effect of rfb mutations on TCP expression might be peculiar to the 569B strain background. The rfbB::pSC95 mutant of 569B (SC539) was therefore analyzed for surface TCP production by IEM (Fig. 2b) and CTX phage transduction (Table 2). SC539 did not display reduced surface expression of TCP relative to 569B by either criterion. It was not possible to determine whether TCP-mediated autoagglutination was affected by the rfbB::pSC95 mutation in 569B, because TCP-mediated autoagglutination is so poor in 569B that it would not be observable against the background autoagglutination caused by the LPS defect.
These data suggested that TCP production might be affected by rfbD mutations but not by rfbB mutations. These two genes act at slightly different points in the O-antigen biosynthetic pathway, and an rfbD mutation could conceivably result in the accumulation of intermediates that somehow interfere with TcpA export. This seemed unlikely because rfbD is immediately downstream of rfbB in the rfb operon (32), and the rfbB::pSC95 mutations are almost certainly polar on rfbD. However, we were able to address the issue definitively by examining TCP expression in an rfbD::Tn5lac mutant of O395 (O395-R2; gift of M. Waldor). O395-R2 showed wild-type, TCP-mediated autoagglutination and wild-type production of TCP when examined by IEM (Fig. 2d) and CTX phage transduction (Table 2). This demonstrates conclusively that TCP expression in O395 is not affected by either rfbB or rfbD mutations.
It may be that because TCP expression is much weaker in 569B than in O395, an rfb-related defect in TcpA translocation could under certain circumstances be observed in 569B. Subtle differences in culture conditions have long been known to have profound effects on TCP production (23), and such effects might account for the detection of a relationship between rfb mutations and TCP in a strain where TCP expression is already low. Nevertheless, the results presented here clearly indicate that, even in 569B, an inability to produce O antigen does not cause a further defect in surface TCP expression.
It remains possible that rfb mutations reduce colonization via a more subtle effect on TCP function. Type IV pilins in Neisseria meningitidis, Neisseria gonorrhoeae, and Pseudomonas aeruginosa are glycosylated (10, 25, 31), and glycosylation has been proposed to affect certain aspects of meningococcal pilus function (21, 35). Although LPS biosynthesis genes do not appear to be involved in modification of neisserial pilins, it may be that rfb mutations in V. cholerae affect TCP modification and, therefore, colonization without grossly affecting TCP biogenesis. However, since there is currently no evidence that TCP are glycosylated, we suggest that LPS itself is important for colonization. This conclusion is not unprecedented, given that LPS mutations have been found to affect colonization in several enteric bacteria, including Yersinia enterocolitica (40), E. coli (8, 9), Salmonella typhimurium (20), and Shigella flexneri (28). Although the exact role of LPS in colonization is unknown, LPS is known to be involved in resistance to antibiotics and complement-mediated killing (26, 27). One possibility is that LPS defects might render bacteria more susceptible to gut-associated bacteriocidal substances. Additional studies with V. cholerae could focus on differences between TCP and LPS mutants (e.g., sensitivity to bile salts, proteases, lactoferrin, and intestinal defensins) that might provide an explanation for the intestinal colonization defect exhibited by LPS mutants.
| |
ACKNOWLEDGMENTS |
|---|
We thank M. Ericsson for assistance with the electron microscopy.
This work was supported by National Institutes of Health grant AI26289 (to J.J.M.). S.L.C. is an Illick Fellow of the Ryan Foundation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Molecular Genetics and Shipley Institute of Medicine, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 432-0767. Fax: (617) 738-7664. E-mail: jmekalan{at}warren.med.harvard.edu.
Editor: P. E. Orndorff
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Attridge, S. R., and D. Rowley. 1983. The role of the flagellum in the adherence of Vibrio cholerae. J. Infect. Dis. 147:864-872[Medline]. |
| 2. | Attridge, S. R., and D. Rowley. 1983. The specificity of Vibrio cholerae adherence and the significance of the slime agglutinin as a second mediator of in vitro attachment. J. Infect. Dis. 147:873-881[Medline]. |
| 3. | Attridge, S. R., E. Voss, and P. A. Manning. 1993. The role of toxin-coregulated pili in the pathogenesis of Vibrio cholerae O1 El Tor. Microb. Pathog. 15:421-431[Medline]. |
| 4. |
Baselski, V.,
R. Briggs, and C. Parker.
1977.
Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice.
Infect. Immun.
15:704-712 |
| 5. |
Baselski, V. S.,
R. A. Medina, and C. D. Parker.
1978.
Survival and multiplication of Vibrio cholerae in the upper bowel of infant mice.
Infect. Immun.
22:435-440 |
| 6. |
Baselski, V. S., and C. D. Parker.
1978.
Intestinal distribution of Vibrio cholerae in orally infected infant mice: kinetics of recovery of radiolabel and viable cells.
Infect. Immun.
21:518-525 |
| 7. |
Bieber, D.,
S. W. Ramer,
C.-Y. Wu,
W. J. Murray,
T. Tobe,
R. Fernandez, and G. K. Schoolnik.
1998.
Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli.
Science
280:2114-2118 |
| 8. | Bilge, S. S., J. C. Vary, Jr., S. F. Dowell, and P. I. Tarr. 1996. Role of the Escherichia coli O157:H7 O side chain in adherence and analysis of an rfb locus. Infect. Immun. 64:4795-4801[Abstract]. |
| 9. |
Brown, P. K., and R. I. Curtiss.
1996.
Unique chromosomal regions associated with virulence of an avian pathogenic Escherichia coli strain.
Proc. Natl. Acad. Sci. USA
93:11149-11154 |
| 10. | Castric, P. 1995. pilO, a gene required for glycosylation of Pseudomonas aeruginosa 1244 pilin. Microbiology 141:1247-1254[Abstract]. |
| 11. | Chiang, S. L., and J. J. Mekalanos. 1998. Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization. Mol. Microbiol. 27:797-806[Medline]. |
| 12. | Chiang, S. L., R. K. Taylor, M. Koomey, and J. J. Mekalanos. 1995. Single amino acid substitutions in the N-terminus of Vibrio cholerae TcpA affect colonization, autoagglutination, and serum resistance. Mol. Microbiol. 17:1133-1142[Medline]. |
| 13. |
Fallarino, A.,
C. Mavrangelos,
U. H. Stroeher, and P. A. Manning.
1997.
Identification of additional genes required for O-antigen biosynthesis in Vibrio cholerae O1.
J. Bacteriol.
179:2147-2153 |
| 14. | Hammerschmidt, S., C. Birkholz, U. Zähringer, B. D. Robertson, J. van Putten, O. Ebeling, and M. Frosch. 1994. Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol. Microbiol. 11:885-896[Medline]. |
| 15. |
Herrington, D. A.,
R. H. Hall,
G. Losonsky,
J. J. Mekalanos,
R. K. Taylor, and M. M. Levine.
1988.
Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.
J. Exp. Med.
168:1487-1492 |
| 16. | Hong, M., and S. M. Payne. 1997. Effect of mutations in Shigella flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance. Mol. Microbiol. 24:779-791[Medline]. |
| 17. |
Iredell, J. R., and P. A. Manning.
1997.
Outer membrane translocation arrest of the TcpA pilin subunit in rfb mutants of Vibrio cholerae O1 strain 569B.
J. Bacteriol.
179:2038-2046 |
| 18. | Kaper, J. B., A. Fasano, and M. Trucksis. 1994. Toxins of Vibrio cholerae, p. 145-176. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C. |
| 19. | Kaufman, M. R., and R. K. Taylor. 1994. The toxin-coregulated pilus: biogenesis and function, p. 187-202. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C. |
| 20. | Licht, T. R., K. A. Krogfelt, P. S. Cohen, L. K. Poulsen, J. Urbance, and S. Molin. 1996. Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization. Infect. Immun. 64:3811-3817[Abstract]. |
| 20a. | Lin, W. Unpublished data. |
| 21. | Marceau, M., K. Forest, J.-L. Béretti, J. Tainer, and X. Nassif. 1998. Consequences of the loss of O-linked glycosylation of meningococcal type IV pilin on piliation and pilus-mediated adhesion. Mol. Microbiol. 27:705-715[Medline]. |
| 22. |
Miller, V. L.,
V. J. DiRita, and J. J. Mekalanos.
1989.
Identification of toxS, a regulatory gene whose product enhances ToxR-mediated activation of the cholera toxin promoter.
J. Bacteriol.
171:1288-1293 |
| 23. |
Miller, V. L., and J. J. Mekalanos.
1988.
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.
J. Bacteriol.
170:2575-2583 |
| 24. | Ottemann, K. M., and J. J. Mekalanos. 1994. Regulation of cholera toxin expression, p. 177-185. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C. |
| 25. | Parge, H. E., K. T. Forest, M. J. Hickey, D. A. Christensen, E. D. Getzoff, and J. A. Tainer. 1995. Structure of the fibre-forming protein pilin at 2.6 Å resolution. Nature 378:32-38[Medline]. |
| 26. | Raetz, C. R. H. 1996. Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles, p. 1035-1063. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. ASM Press, Washington, D.C. |
| 27. | Roantree, R. J. 1967. Salmonella O antigen and virulence. Annu. Rev. Microbiol. 21:443-466[Medline]. |
| 28. | Sandlin, R. C., K. A. Lampel, S. P. Keasler, M. B. Goldberg, A. L. Stolzer, and A. T. Maurelli. 1995. Avirulence of rough mutants of Shigella flexneri: requirement of O antigen for correct unipolar localization of IcsA in the bacterial outer membrane. Infect. Immun. 63:229-237[Abstract]. |
| 29. |
Sigel, S. P.,
S. Lanier,
V. S. Baselski, and C. D. Parker.
1980.
In vivo evaluation of pathogenicity of clinical and environmental isolates of Vibrio cholerae.
Infect. Immun.
28:681-687 |
| 30. | Slauch, J. M., M. J. Mahan, P. Michetti, M. R. Neutra, and J. J. Mekalanos. 1995. Acetylation (O-factor 5) affects the structural and immunological properties of Salmonella typhimurium lipopolysaccharide O antigen. Infect. Immun. 63:437-441[Abstract]. |
| 31. | Stimson, E., M. Virji, K. Makepeace, A. Dell, H. R. Morris, G. Payne, J. R. Saunders, M. P. Jennings, S. Barker, M. Panico, I. Blench, and E. R. Moxon. 1995. Meningococcal pilin: a glycoprotein substituted with digalactosyl 2,4-diacetamido-2,4,6-trideoxyhexose. Mol. Microbiol. 17:1201-1214[Medline]. |
| 32. |
Stroeher, U. H.,
L. E. Karageorgos,
R. Morona, and P. A. Manning.
1992.
Serotype conversion in Vibrio cholerae O1.
Proc. Natl. Acad. Sci. USA
89:2566-2570 |
| 33. |
Taylor, R. K.,
V. L. Miller,
D. B. Furlong, and J. J. Mekalanos.
1987.
Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.
Proc. Natl. Acad. Sci. USA
84:2833-2837 |
| 34. | Thelin, K. H., and R. K. Taylor. 1996. Toxin-coregulated pilus, but not mannose-sensitive hemagglutinin, is required for colonization by Vibrio cholerae O1 El Tor biotype and O139 strains. Infect. Immun. 64:2853-2856[Abstract]. |
| 35. | Virji, M., J. R. Saunders, G. Sims, K. Makepeace, D. Maskell, and D. J. P. Ferguson. 1993. Pilus-facilitated adherence of Neisseria meningitidis to human epithelial and endothelial cells: modulation of adherence phenotype occurs concurrently with changes in primary amino acid sequence and the glycosylation status of pilin. Mol. Microbiol. 10:1013-1028[Medline]. |
| 36. |
Waldor, M. K.,
R. Colwell, and J. J. Mekalanos.
1994.
The Vibrio cholerae O139 serogroup antigen includes O-antigen capsule and lipopolysaccharide virulence determinants.
Proc. Natl. Acad. Sci. USA
91:11388-11392 |
| 37. | Waldor, M. K., and J. J. Mekalanos. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910-1914[Abstract]. |
| 38. |
Waldor, M. K., and J. J. Mekalanos.
1994.
ToxR regulates virulence gene expression in non-O1 strains of Vibrio cholerae that cause epidemic cholera.
Infect. Immun.
62:72-78 |
| 39. | Ward, H. M., and P. A. Manning. 1989. Mapping of chromosomal loci associated with lipopolysaccharide synthesis and serotype specificity in Vibrio cholerae O1 by transposon mutagenesis using Tn5 and Tn2680. Mol. Gen. Genet. 218:367-370[Medline]. |
| 40. | Zhang, L., J. Radziejewska-Lebrecht, D. Krajewska-Pietrasik, P. Toivanen, and M. Skurnik. 1997. Molecular and chemical characterization of the lipopolysaccharide O-antigen and its role in the virulence of Yersinia enterocolitica serotype O:8. Mol. Microbiol. 23:63-76[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|